Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Picterus AS
- Study ID
- NCT05521607
- Status
- Recruiting
Conditions
- Neonatal Jaundice
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Day - 14 Days
- Healthy Volunteers
- Accepted
Interventions
- Picterus Jaundice Pro (JP) — DEVICEUse Picterus Jaundice Pro, a smartphone app that is used to take photo of the newborns skin, where the Picterus calibration card is place.
Study Details
A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.
Key Dates
- Start date
- Jan 6, 2023
- Status verified
- Sep 2024
- Primary completion
- Oct 31, 2024
- Completion
- Jun 15, 2025
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: Enable high qualitative estimation of bilirubin levels in the blood of new-bornsThere is only one arm in this study which is to enable high qualitative estimation of bilirubin levels in the blood of new-borns, independent of skin color, using Picterus JP.
Primary Outcome Measure
Enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP. [ Time Frame: 3-6 months ]
Central Contacts
- Jeanmarie Schied, MD7737029200
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Chicago | Chicago | Illinois | 60637 |
Find similar trials in Chicago, IL
By research site